The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 01, 2022

Filed:

Jun. 04, 2018
Applicants:

Merck Patent Gmbh, Darmstadt, DE;

Ablynx NV, Zwijnaarde, BE;

Inventors:

Marie-Ange Buyse, Merelbeke, BE;

Guy Hermans, Merelbeke, BE;

Sven Lindemann, Darmstadt, DE;

Hans Guehring, Geissenheim, DE;

Ralf Guenther, Griesheim, DE;

Roland Kellner, Heppenheim, DE;

Assignees:

Merck Patent GmbH, Darmstadt, DE;

ABLYNX NV, Zwijnaarde, BE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/18 (2006.01); C07K 16/40 (2006.01); A61K 39/00 (2006.01); A61P 19/02 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); C07K 16/18 (2013.01); C07K 16/40 (2013.01); A61K 2039/505 (2013.01); A61P 19/02 (2018.01); C07K 2317/33 (2013.01); C07K 2317/569 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present invention relates to immunoglobulins that bind ADAMTS5 and more in particular to polypeptides, that comprise or essentially consist of one or more such immunoglobulins. The invention also relates to constructs comprising such immunoglobulins, such as immunoglobulin single variable domains (ISVDs) or polypeptides as well as nucleic acids encoding such immunoglobulins or polypeptides; to methods for preparing such immunoglobulins, polypeptides and constructs; to host cells expressing or capable of expressing such immunoglobulins or polypeptides; to compositions, and in particular to pharmaceutical compositions, that comprise such immunoglobulins, polypeptides, constructs, nucleic acids and/or host cells; and to uses of immunoglobulins, polypeptides, constructs, nucleic acids, host cells and/or compositions, in particular for prophylactic and/or therapeutic purposes, such as the prophylactic and/or therapeutic purposes mentioned herein. Other aspects, embodiments, advantages and applications of the invention will become clear from the further description herein.


Find Patent Forward Citations

Loading…